J, P., R, T., DPC, v. D., LJ, S., P, H., JGMC, D., & P, v. P. (2026). Soluble immune checkpoints reflect immune activation and treatment response in high-risk systemic sclerosis patients treated with plasma exchange. Journal of translational autoimmunity, 12, 100361. https://doi.org/10.1016/j.jtauto.2026.100361
Chicago Style (17th ed.) CitationJ, Potjewijd, Tobal R, van Doorn DPC, Schurgers LJ, Heeringa P, Damoiseaux JGMC, and van Paassen P. "Soluble Immune Checkpoints Reflect Immune Activation and Treatment Response in High-risk Systemic Sclerosis Patients Treated with Plasma Exchange." Journal of Translational Autoimmunity 12 (2026): 100361. https://doi.org/10.1016/j.jtauto.2026.100361.
MLA (9th ed.) CitationJ, Potjewijd, et al. "Soluble Immune Checkpoints Reflect Immune Activation and Treatment Response in High-risk Systemic Sclerosis Patients Treated with Plasma Exchange." Journal of Translational Autoimmunity, vol. 12, 2026, p. 100361, https://doi.org/10.1016/j.jtauto.2026.100361.